MS Research Roundup: August 13, 2014

Cover vol. 11, no. 4, August 2014

August 2014 20 − −

IDSA Ebola Summary—August 2014

We write to provide an update on the evolving Ebola outbreak in West Africa. Of particular relevance for infectious disease specialists is information on the identification and care of possible imported cases of Ebola virus disease (EVD) in the United States. This communication is current as of August 21, 2014, and contains links to the sources where anticipated updates will be found in the nea...

Acute Flaccid Myelitis Among Persons Aged ≤21 Years — United States, August 1–November 13, 2014

Division of Viral Diseases, National Centers for Immunization and Respiratory Diseases, CDC; Division of Vector-Borne Diseases, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, CDC; Children’s Hospital Colorado; Council of State and Territorial Epidemiologists In August 2014, physicians at Children’s Hospital Colorado in Aurora...

On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneu-

822 MMWR / September 19, 2014 / Vol. 63 / No. 37 On August 13, 2014, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of 13-valent pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a subsidiary of Pfizer Inc.]) among adults aged ≥65 years. PCV13 should be administered in series with the 23-valent pneumococcal polysaccharide vaccine (P...